The UK Medical Devices Regulations (UK MDR) are vital for ensuring the safety, performance, and quality of medical devices in the UK. However, the regulatory landscape for medical devices in the UK has undergone substantial changes post-Brexit, presenting new — and ever-changing — challenges for manufacturers.
RAPS and TOPRA are excited to jointly present a new conference that will offer a deeper understanding of the UK MDR and its impact on the current regulatory landscape. With a primary focus on regulatory innovation, the event will also explore how the adoption process is developing and what mechanisms are in place to support the introduction of high value-added new products which have the potential to both enhance outcomes for patients and drive operational efficiency in the NHS.